New functional imaging modalities for chromaffin tumors, neuroblastomas and ganglioneuromas
- 31 March 2005
- journal article
- review article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 16 (2) , 66-72
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- Malignant pheochromocytoma: current status and initiatives for future progressEndocrine-Related Cancer, 2004
- First 18F-Labeled Tracer Suitable for Routine Clinical Imaging of sst Receptor-Expressing Tumors Using Positron Emission TomographyClinical Cancer Research, 2004
- Octreotide Scintigraphy in the Head and NeckThe Laryngoscope, 2004
- Pheochromocytoma and functional paragangliomaCurrent Opinion in Oncology, 2004
- Potential and Practical Adrenomedullary PET Radiopharmaceuticals as an Alternative to m-Iodobenzylguanidine: m-(ω-[18F]Fluoroalkyl)benzylguanidinesBioconjugate Chemistry, 2003
- Is preoperative iodine 123 meta-iodobenzylguanidine scintigraphy routinely necessary before initial adrenalectomy for pheochromocytoma?Surgery, 2003
- Octreotide Scintigraphy for the Detection of ParagangliomasOtolaryngology–Head and Neck Surgery, 2000
- Case Report. Malignant Pheochromocytoma of the Anterior Mediastinum: PET Findings with [18F]FDG and 82RbJournal of Computer Assisted Tomography, 1996
- FDG PET imaging of paragangliomas of the neck: comparison with MIBG SPETEuropean Journal of Nuclear Medicine and Molecular Imaging, 1995
- In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomasThe Journal of Clinical Endocrinology & Metabolism, 1992